ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $642,000 | -28.2% | 6,863 | -31.5% | 0.00% | – |
| Q2 2023 | $894,000 | +735.5% | 10,013 | +901.3% | 0.00% | – |
| Q1 2023 | $107,000 | -18.3% | 1,000 | -6.2% | 0.00% | – |
| Q4 2022 | $131,000 | -15.5% | 1,066 | -29.1% | 0.00% | – |
| Q3 2022 | $155,000 | -32.6% | 1,503 | -39.2% | 0.00% | – |
| Q2 2022 | $230,000 | -18.1% | 2,474 | +3.6% | 0.00% | – |
| Q1 2022 | $281,000 | +26.0% | 2,389 | +44.2% | 0.00% | – |
| Q4 2021 | $223,000 | -35.4% | 1,657 | -23.5% | 0.00% | – |
| Q3 2021 | $345,000 | +41.4% | 2,166 | +16.7% | 0.00% | – |
| Q2 2021 | $244,000 | +5.6% | 1,856 | +3.9% | 0.00% | – |
| Q1 2021 | $231,000 | -11.2% | 1,787 | +14.6% | 0.00% | – |
| Q4 2020 | $260,000 | +31.3% | 1,560 | +21.6% | 0.00% | – |
| Q3 2020 | $198,000 | +9.4% | 1,283 | +4.8% | 0.00% | – |
| Q2 2020 | $181,000 | +79.2% | 1,224 | +36.0% | 0.00% | – |
| Q1 2020 | $101,000 | -19.2% | 900 | 0.0% | 0.00% | – |
| Q4 2019 | $125,000 | +42.0% | 900 | -1.6% | 0.00% | – |
| Q3 2019 | $88,000 | -17.0% | 915 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | 0.0% | 915 | +1.7% | 0.00% | – |
| Q1 2019 | $106,000 | +68.3% | 900 | -10.0% | 0.00% | – |
| Q4 2018 | $63,000 | -11.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $71,000 | – | 1,000 | +33233.3% | 0.00% | – |
| Q2 2018 | $0 | – | 3 | -25.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 4 | -78.9% | 0.00% | – |
| Q4 2017 | $1,000 | – | 19 | +216.7% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 6 | -85.7% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 42 | -77.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |